Home Health & Wellness Obesity Significantly Heightens Postmenopausal Breast Cancer Risk, Reveals New Study

Obesity Significantly Heightens Postmenopausal Breast Cancer Risk, Reveals New Study

Published: Last updated:
Reading Time: 3 minutes

A new comprehensive study has shed light on the critical relationship between body mass index (BMI) and breast cancer prognosis, emphasising the heightened risks associated with obesity. The research, which aggregates data from 46 studies involving 295,260 patients, underscores the complex interplay between BMI and breast cancer outcomes, particularly highlighting the differential impacts on premenopausal and postmenopausal women. The findings were published in the journal Medicine.

The study, conducted through a rigorous meta-analysis, reveals that obesity significantly increases the risk of developing breast cancer in postmenopausal women. According to the findings, women with a BMI classified as obese are at a markedly higher risk of breast cancer compared to those with a normal BMI​​. This aligns with previous research suggesting that the hormonal changes associated with higher body fat percentages, such as increased estrogen levels, may fuel the growth of certain types of breast cancer​​.

Nikolaos Tzenios, PhD, a researcher from Charisma University and the lead author of the study, said: “The motivation for our study stemmed from the ongoing debate and inconsistent findings regarding the relationship between body mass index (BMI) and breast cancer risk. Breast cancer remains a leading cause of cancer mortality among women worldwide, and identifying modifiable risk factors such as obesity is crucial for developing effective prevention strategies.”

Interestingly, the relationship between BMI and breast cancer risk in premenopausal women appears to be more nuanced. The study found no significant correlation between elevated BMI and breast cancer incidence in this group. This could be due to the protective effects of higher weight in premenopausal women, such as longer anovulatory cycles and lower lifetime exposure to estrogen and progesterone​​.

Tzenios further elaborated on the study’s findings: “Our meta-analysis, which included data from 102 studies involving over 2 million participants, revealed a significant association between obesity and an increased risk of breast cancer in postmenopausal women. Specifically, we found that obese postmenopausal women had a 26% higher risk of developing breast cancer compared to their normal-weight counterparts. Conversely, no significant relationship was found between overweight status and breast cancer in premenopausal women.”

Beyond the risk of developing breast cancer, the study also delved into the impact of BMI on survival rates and prognosis. It was observed that higher BMI is associated with poorer outcomes in breast cancer patients, particularly in terms of disease-free survival and overall survival rates. Obese patients, especially those with metastatic breast cancer, tend to have worse prognoses compared to their normal-weight counterparts.

One notable aspect of the study is its examination of the impact of BMI on different breast cancer subtypes. For instance, in patients with HER2-positive breast cancer, those with higher BMI showed an increased incidence of distant metastases, which are associated with a poorer prognosis. Similarly, the study highlighted that overweight and obese patients with triple-negative breast cancer, a particularly aggressive form of the disease, also face worse outcomes​​.

The precise mechanisms linking high BMI to poorer breast cancer outcomes remain an active area of research. However, several hypotheses have been proposed. One theory suggests that the increased adipose tissue in obese individuals leads to higher levels of insulin and insulin-like growth factors, which can promote tumour growth. Additionally, obesity is often associated with chronic inflammation, which may contribute to cancer progression​​.

Another factor could be the difficulty in diagnosing and treating breast cancer in obese patients. Higher BMI can make physical examinations and imaging tests less effective, potentially leading to later-stage diagnoses and more complex treatment pathways​​.

The findings of this study have significant implications for both clinical practice and public health strategies. Clinicians are urged to consider BMI as a critical factor in breast cancer risk assessments and treatment planning. For overweight and obese patients, personalised interventions that include weight management and lifestyle modifications could be beneficial in improving prognosis and survival outcomes​​.

Tzenios outlined future plans to build on these findings: “Moving forward, we aim to delve deeper into the biological mechanisms linking obesity and breast cancer. This includes exploring the roles of inflammatory markers, hormonal changes, and metabolic alterations associated with obesity. We also plan to conduct longitudinal studies to assess the impact of weight management interventions on reducing breast cancer risk.”

From a public health perspective, the study underscores the importance of addressing obesity as a modifiable risk factor for breast cancer. Efforts to promote healthy weight through diet, physical activity, and broader societal changes are essential in reducing the burden of breast cancer, particularly among postmenopausal women​​.

Tzenios also emphasised the importance of international collaboration: “We intend to collaborate with international research groups to enhance the generalisability of our findings across diverse populations and settings.”

© Copyright 2014–2034 Psychreg Ltd